🇺🇸 Acarbose Tablets in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Pneumonia — 2 reports (18.18%)
  2. Abdominal Pain — 1 report (9.09%)
  3. Anaemia — 1 report (9.09%)
  4. Angina Unstable — 1 report (9.09%)
  5. Bile Duct Stone — 1 report (9.09%)
  6. Blood Glucose Increased — 1 report (9.09%)
  7. Drug Dose Omission — 1 report (9.09%)
  8. Drug Ineffective — 1 report (9.09%)
  9. Dysgeusia — 1 report (9.09%)
  10. Erythema — 1 report (9.09%)

Source database →

Other Diabetes approved in United States

Frequently asked questions

Is Acarbose Tablets approved in United States?

Acarbose Tablets does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Acarbose Tablets in United States?

University of Alabama at Birmingham is the originator. The local marketing authorisation holder may differ — check the official source linked above.